N/A
Completed N=32
BradyXplore Phase II: Bradykinesia Feature Extraction System
Source: ClinicalTrials.gov NCT02358876 ↗Enrolled (actual)
32
Serious AEs
0.0%
Results posted
Oct 2016
Primary outcomePrimary: Percentage of Kinesia One Assessments Performed — 99 percentage of home assessments completed
Summary
Study objectives are to improve motion sensor algorithms for measuring bradykinesia in the clinic and the home, evaluate test-retest reliability of motion sensor algorithms for measuring bradykinesia compared to clinician raters, determine if participant-perceived symptom severities correlate with motion sensor measures, determine if speed, amplitude, and rhythm fluctuate differentially throughout the day in individuals with implanted deep brain stimulation systems, receive feedback on the usability of Kinesia One, and evaluate Kinesia One compliance in the home.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Kinesia One Assessments Performed |
99 | — |
Eligibility Criteria
Inclusion Criteria
- Diagnosis of idiopathic Parkinson's disease
- Has Deep Brain Stimulation Implant for Parkinson's disease
- Historical bradykinesia rating of 2 or greater on at least one of the Unified Parkinson's Disease Rating Scale (UPDRS) finger-tapping, hand-movements, and pronation-supination tasks with DBS off.
Exclusion Criteria
- Dementia (MoCA < 25)
Data sourced from ClinicalTrials.gov (NCT02358876). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.